Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
4.00
-0.26 (-6.10%)
At close: Aug 15, 2025, 3:59 PM
4.02
0.63%
After-hours: Aug 15, 2025, 07:34 PM EDT
Larimar Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 241K | 241K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 161K | 241K | 322K | 317K | 279K | 253K | 204K | 212K | 244K | 272K | 328K | 339K | 335K | 326K | 238K | 150K | 73K |
Gross Profit | 80K | n/a | -322K | -317K | -279K | -253K | -204K | -212K | -244K | -272K | -328K | -339K | -335K | -326K | -238K | -150K | -73K |
Operating Income | -105.34M | -90.89M | -73.76M | -65.83M | -50.85M | -41.76M | -38.03M | -36.21M | -35.28M | -36.53M | -35.17M | -43.39M | -47.25M | -50.47M | -55.77M | -49.38M | -48.23M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -95.23M | -80.6M | -64.77M | -58.34M | -45.08M | -36.95M | -33.38M | -32.64M | -32.94M | -35.35M | -35.06M | -43.55M | -47.49M | -50.64M | -55.7M | -49.17M | -47.9M |
Net Income | -95.23M | -80.6M | -64.77M | -58.34M | -45.08M | -35.84M | -31.26M | -30.32M | -30.6M | -34.18M | -34.91M | -43.59M | -47.55M | -50.64M | -55.7M | -49.17M | -47.9M |
Selling & General & Admin | 18.55M | 17.71M | 16.67M | 16.08M | 14.81M | 14.09M | 13.79M | 12.97M | 12.27M | 12.28M | 11.85M | 11.62M | 12.02M | 12.07M | 13.11M | 13.82M | 12.87M |
Research & Development | 86.8M | 73.11M | 56.94M | 49.61M | 35.89M | 27.59M | 24.24M | 23.24M | 23.01M | 24.25M | 23.32M | 31.77M | 35.23M | 38.4M | 42.67M | 35.56M | 35.36M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20K | -36K | -84K | -159K | -245K | -171K | -123K | 13K | 148K |
Operating Expenses | 105.26M | 90.72M | 73.51M | 65.59M | 50.69M | 41.68M | 38.03M | 36.21M | 35.28M | 36.53M | 35.17M | 43.39M | 47.25M | 50.47M | 55.77M | 49.38M | 48.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 56K | 56K | 56K | 56K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 100K | 100K | 100K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 74.56M | 91.3M | 73.76M | 65.83M | 50.85M | 41.76M | 38.03M | 36.21M | 35.28M | 36.53M | 35.17M | 43.39M | 47.25M | 50.47M | 55.77M | 49.38M | 48.23M |
Income Tax Expense | n/a | 36.72K | 73.91K | -2.09K | -48.17K | -1.2M | -2.25M | -2.36M | -2.34M | -1.17M | -245K | -52K | -32K | -88K | -50K | -100K | -132K |
Shares Outstanding (Basic) | 63.96M | 63.81M | 63.81M | 63.8M | 53.55M | 43.91M | 43.9M | 43.9M | 43.9M | 23.99M | 22.23M | 18.34M | 18.34M | 18.34M | 18.29M | 16M | 16M |
Shares Outstanding (Diluted) | 63.96M | 63.81M | 63.81M | 63.8M | 53.55M | 43.91M | 43.9M | 43.9M | 43.9M | 23.99M | 22.23M | 18.34M | 18.34M | 18.34M | 18.29M | 16M | 16M |
EPS (Basic) | -1.51 | -1.32 | -1.15 | -1.12 | -0.97 | -0.82 | -0.87 | -1.03 | -1.31 | -1.68 | -1.83 | -2.38 | -2.7 | -2.97 | -3.36 | -3.08 | -3.5 |
EPS (Diluted) | -1.51 | -1.32 | -1.15 | -1.12 | -0.97 | -0.82 | -0.87 | -1.03 | -1.31 | -1.68 | -1.83 | -2.38 | -2.7 | -2.97 | -3.36 | -3.08 | -3.5 |
EBITDA | -105.09M | -90.65M | -73.51M | -65.51M | -50.54M | -41.45M | -37.73M | -35.9M | -34.96M | -36.21M | -34.84M | -43.05M | -46.91M | -50.14M | -55.49M | -49.13M | -48.03M |
EBIT | -71.69M | -88.42M | -73.76M | -65.83M | -50.85M | -41.76M | -38.03M | -36.21M | -35.28M | -36.53M | -35.17M | -43.39M | -47.25M | -50.47M | -55.77M | -49.38M | -48.24M |
Depreciation & Amortization | 238K | 318K | 322K | 317K | 279K | 277K | 228K | 236K | 268K | 272K | 328K | 339K | 335K | 326K | 288K | 250K | 205K |